News | August 08, 2023
Gland Pharma posts Q1 FY24 consolidated PAT at Rs. 194.10 Cr
Gland Pharma has reported total income of Rs. 1246.23 crores during the period ended June 30, 2023
Gland Pharma has reported total income of Rs. 1246.23 crores during the period ended June 30, 2023
The inspection closed with zero observations and a classification of No Action Indicated
The company has reported total income of Rs. 115.37 crores during the period ended June 30, 2023
Fortis Healthcare has reported total income of Rs. 1665.55 crores during the period ended June 30, 2023
The company has reported total income of Rs. 310.07 crores during the period ended June 30, 2023
Aiming to establish a state-of-the-art healthcare facility in India that integrates the latest technologies, exceptional patient comfort, and optimal clinical outcomes
The company has reported total income of Rs. 704.5 crores during the period ended June 30, 2023
The company has reported total income of Rs. 4836.89 crores during the period ended June 30, 2023
The company has reported total income of Rs. 1787.16 crores during the period ended June 30, 2023
DeltaV control system natively integrated into Sartorius Biostat STR bioreactors provide a foundation for semi-autonomous operations and up to 80% less integration time
Subscribe To Our Newsletter & Stay Updated
